MAP-315

N/A

Report date: 2023/08/30 13:10:06

Base Information

Drug NameMAP-315
Drug Alias NameMAP-315MAP315
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMicroba Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMicroba Pty Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A